MicroPhage Secures $9,560,258 New Funding

  • Feed Type
  • Date
    9/30/2011
  • Company Name
    MicroPhage
  • Mailing Address
    2400 Trade Centre Avenue Longmont, CO 80503
  • Company Description
    MicroPhage’s mission is to be a worldwide leader in rapid bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
  • Website
    http://www.microphage.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $9,560,258
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filings.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy